Across rheumatic diseases

Health and Economic Outcomes Associated With Musculoskeletal Disorders Attributable to High Body Mass Index in 192 Countries and Territories in 2019

JAMA Netw OpenPublished Cross-sectional study

Authors' conclusion

In this cross-sectional study of 192 countries and territories, a substantial amount of the health and economic impact of musculoskeletal disorders was attributable to high BMI.

Study context

Population
192 countries and territories; data from GBD Study, WHO Global Health Expenditure, World Bank and International Labour Organization databases, 2019192 countries and territories
Outcome
Prevalence, YLDs, health care costs and productivity losses due to morbidity from LBP, gout and OA attributable to high BMI, by region and country
Follow-up
2019
Methodological detailspopulation attributable fraction approach, sensitivity analysis (UI), Data analyses conducted from February 24 to June 16, 2022
  • Population attributable fraction approach
  • Sensitivity analysis (UI)
  • Data analyses conducted from February 24 to June 16, 2022

Main finding

As reported in the abstract

Musculoskeletal disorders attributable to high BMI, 2019
Prevalent cases of LBP attributable to high body mass index (BMI)
36.3 million (UI, 18.4-61.0 million)
Prevalent cases of gout attributable to high BMI
16.9 million (UI, 7.5-32.5 million)
Prevalent cases of OA attributable to high BMI
73.0 million (UI, 32.4-131.1 million)
Years lived with disability (YLDs)
7.3 million (UI, 3.0-15.0 million)
Share of all-cause YLDs, working-age population aged 15 to 84 years
1.0%
Global total costs (UI, $83.8-$333.1 billion)
$180.7 billion
Health care costs (UI, $30.7-$100.5 billion)
$60.5 billion
Productivity losses (UI, $53.1-$232.7 billion)
$120.2 billion

Observational data: associations, not effects.

Further findings

Health care costs by payer sector · 2019

Public sector
58.9% ($35.6 billion; UI, $17.8-$59.6 billion)
Private sector
24.0% ($14.5 billion; UI, $7.8-$23.2 billion)
Out-of-pocket sector
17.1% ($10.3 billion; UI, $5.1-$17.6 billion)

Total costs as share of global gross domestic product · 2019

Share of global gross domestic product (on average)
0.2%

Inequalities across regions and countries · 2019

Global health care costs paid by high-income countries
82.4%
Morbidity-related costs paid by high-income countries
82.9%
Global YLDs occurring in middle-income countries
61.4%

Original publication

Health and Economic Outcomes Associated With Musculoskeletal Disorders Attributable to High Body Mass Index in 192 Countries and Territories in 2019. JAMA Netw Open. Published 3 January 2023. doi:10.1001/jamanetworkopen.2022.50674

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.